Zobrazeno 1 - 10
of 12
pro vyhledávání: '"van Mackelenbergh MT"'
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer.
Autor:
O'Regan RM; University of Rochester Department of Medicine, Rochester, New York., Zhang Y; Biotheranostics, A Hologic Company, San Diego, California., Fleming GF; The University of Chicago Medical Center, Chicago, Illinois., Francis PA; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia.; St Vincent's Hospital, Melbourne, Australia.; Breast Cancer Trials Australia & New Zealand, Newcastle, Australia.; University of Newcastle, Callaghan, Newcastle, Australia., Kammler R; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland., Viale G; International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology IRCCS, Milan, Italy.; Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy., Dell'Orto P; Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy., Lang I; Clinexpert-Research, Budapest, Hungary., Bellet M; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain., Bonnefoi HR; Institut Bergonie Comprehensive Cancer Center, Universite de Bordeaux, INSERM U1312, Bordeaux, France.; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Tondini C; Ospedale Papa Giovanni XXIII, Bergamo, Italy., Villa F; Oncology Unit, Department of Oncology, Alessandro Manzoni Hospital, ASST Lecco, Lecco, Italy., Bernardo A; Operative Unit of Medical Oncology, IRCCS ICS Maugeri, Pavia, Italy., Ciruelos EM; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain.; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain., Neven P; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Gynecologic Oncology and Multidisciplinary Breast Center, University Hospitals UZ Leuven, KU Leuven, Leuven, Belgium., Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Müller B; Chilean Cooperative Group for Oncologic Research (GOCCHI), Santiago, Chile., Jochum W; Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Zaman K; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Breast Center, Lausanne University Hospital CHUV, Lausanne, Switzerland., Martino S; The Angeles Clinic and Research Institute, Santa Monica, California.; SWOG Cancer Research Network, San Antonio, Texas., Geyer CE Jr; University of Pittsburgh Medical Center Hillman Cancer Center Pittsburgh, Pennsylvania.; NSABP Foundation/NRG Oncology, Pittsburgh, Pennsylvania., Jerzak KJ; Division of Medical Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada., Davidson NE; Fred Hutchinson Cancer Center, University of Washington Seattle, Washington.; ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania., Coleman RE; Weston Park Hospital, Sheffield, United Kingdom.; National Cancer Research Institute, Breast Cancer Clinical Studies Group (NCRI-BCSG), London, United Kingdom.; The Institute for Cancer Research, The Clinical Trials and Statistics Unit (ICR-CTSU), London, United Kingdom., Ingle JN; Mayo Clinic and Alliance for Clinical Trials in Oncology, Rochester, Minnesota., van Mackelenbergh MT; German Breast Group, Neu Isenburg, Germany.; University Hospital of Schleswig-Holstein, Campus Kiel, Germany., Loi S; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne Australia., Colleoni M; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Schnabel CA; Biotheranostics, A Hologic Company, San Diego, California., Treuner K; Biotheranostics, A Hologic Company, San Diego, California., Regan MM; IBCSG Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Oct 01; Vol. 10 (10), pp. 1379-1389.
Autor:
Rambow AC; Department of Gynecology and Obstetrics, University Hospital Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany. anna-christina.rambow@uksh.de., Nikolai M; Department of Gynecology and Obstetrics, University Hospital Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany., Jansen P; Department of Gynecology and Obstetrics, University Hospital Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany., Rogmans C; Department of Gynecology and Obstetrics, University Hospital Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany., Tribian N; Department of Gynecology and Obstetrics, University Hospital Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany., Bauerschlag DO; Department of Gynecology and Obstetrics, University Hospital Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany., Maass N; Department of Gynecology and Obstetrics, University Hospital Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany., van Mackelenbergh MT; Department of Gynecology and Obstetrics, University Hospital Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany.
Publikováno v:
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2024 Aug; Vol. 310 (2), pp. 1207-1213. Date of Electronic Publication: 2024 May 25.
Autor:
Stock S; Faculty of Medicine, University of Cologne and Institute for Health Economics and Clinical Epidemiology, Cologne; Faculty of Medicine, University of Cologne and Center for Familial Breast and Ovarian Cancer, University Hospital Cologne; Faculty of Medicine, University of Cologne and Institute for Health Economics and Clinical Epidemiology, Cologne; Institute for Public Health and Healthcare Research, University of Bremen; Institute for Human Genetics, University Hospital Heidelberg; Department of Obstetrics and Gynecology, Rechts der Isar Hospital Technical University of Munich; Schumpeter School of Business and Economics, Competence Center for Health Economics and Healthcare Research, University of Wuppertal; Department of Obstetrics and Gynecology, Carl Gustav Carus University Hospital, Dresden; Faculty of Medicine, University of Cologne and Center for Familial Breast and Ovarian Cancer, University Hospital Cologne; Institute for Health and Healthcare Science, Martin Luther University of Halle-Wittenberg, Halle (Saale); Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Kiel; Faculty of Medicine, University of Cologne and Department of Psychosomatics and Psychotherapy, University Hospital Cologne; Department of Psychosomatic Medicine, Robert Bosch Hospital, Stuttgart; Department of Obstetrics and Gynecology, University Hospital Würzburg., Isselhard A, Shukri A, Kautz-Freimuth S, Redaèlli M, Berger-Höger B, Dikow N, Kiechle M, Köberlein-Neu J, Meisel C, Schmutzler R, Steckelberg A, van Mackelenbergh MT, Vitinius F, Wöckel A, Rhiem K
Publikováno v:
Deutsches Arzteblatt international [Dtsch Arztebl Int] 2024 Jun 14; Vol. 121 (12), pp. 393-400.
Autor:
Williams TM; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California., Schneeweiss A; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Jackisch C; Sana Klinikum Offenbach, Offenbach, Germany., Shen C; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California., Weber KE; German Breast Group, Neu-Isenburg, Germany., Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Denkert C; Institut für Pathologie Philipps-Universität Marburg, Marburg, Germany., Furlanetto J; German Breast Group, Neu-Isenburg, Germany., Heinmöller E; Pathologie Nordhessen, Kassel, Germany., Schmatloch S; Elisabeth-Krankenhaus Kassel, Germany., Karn T; Department of Gynecology and Obstetrics, Goethe University Frankfurt, Frankfurt, Germany., Szeto CW; NantOmics, LLC, Culver City, California., van Mackelenbergh MT; Universitätsklinikum Schleswig-Holstein, Kiel, Germany., Nekljudova V; German Breast Group, Neu-Isenburg, Germany., Stickeler E; Uniklinik RWTH Achen, Aachen, Germany., Soon-Shiong P; NantOmics, LLC, Culver City, California., Schem C; Mammazentrum Hamburg, Hamburg, Germany., Mairinger T; HELIOS Klinikum Berlin Buch, Berlin, Germany., Müller V; Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Marme F; Universitätsfrauenklinik Mannheim, Mannheim, Germany., Untch M; HELIOS Klinikum Berlin Buch, Berlin, Germany., Loibl S; German Breast Group, Neu-Isenburg, Germany.; Centre for Haematology and Oncology, Bethanien Frankfurt/M, Germany.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 01; Vol. 29 (17), pp. 3384-3394.
Autor:
Squifflet P; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Saad ED; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Loibl S; German Breast Group, Neu-Isenburg, Germany., van Mackelenbergh MT; German Breast Group, Neu-Isenburg, Germany., Untch M; Helios Kliniken Berlin-Buch, Berlin, Germany., Rastogi P; NRG Oncology, Pittsburgh, PA., Gianni L; San Raffaele Scientific Institute, Milan, Italy., Schneeweiss A; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Piccart M; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Bonnefoi H; Institut Bergonié and Université de Bordeaux INSERM U916, Bordeaux, France., Jackisch C; Sana Klinikum Offenbach, Offenbach, Germany., Nekljudova V; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Tang G; University of Pittsburgh, Pittsburgh, PA., Valagussa P; Fondazione Michelangelo, Milan, Italy., Neate C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gelber R; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA., Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Heinzmann D; Product Development-Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Denkert C; Institut für Pathologie, Philipps-Universität Marburg und Universitätsklinikum Marburg, Marburg, Germany., Geyer CE Jr; UPMC Hillman Cancer Center, Pittsburgh, PA., Cortes J; IOB Institute of Oncology, Quiron Group, Madrid & Barcelona and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., de Azambuja E; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Cameron D; Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, Edinburgh, United Kingdom., Ismael G; Fundação Doutor Amaral Carvalho, Jaú, Brazil., Wolmark N; UPMC Hillman Cancer Center, Pittsburgh, PA., Cortazar P; Genentech, Inc, South San Francisco, CA., Buyse M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jun 01; Vol. 41 (16), pp. 2988-2997. Date of Electronic Publication: 2023 Mar 28.
Autor:
van Mackelenbergh MT; Universitaetsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany., Loibl S; German Breast Group, Neu-Isenburg, Germany., Untch M; Helios Kliniken Berlin-Buch, Berlin, Germany., Buyse M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Geyer CE Jr; NSABP Foundation and University of Pittsburgh/Hillman Cancer Center, Pittsburgh, PA., Gianni L; San Raffaele Scientific Institute, Milan, Italy., Schneeweiss A; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Piccart M; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Bonnefoi H; Institut Bergonié and Université de Bordeaux INSERM U916, Bordeaux, France., Jackisch C; Sana Klinikum Offenbach GmbH, Offenbach, Germany., Nekljudova V; German Breast Group, Neu-Isenburg, Germany., Tang G; University of Pittsburgh, Pittsburgh, PA., Valagussa P; Fondazione Michelangelo, Milan, Italy., Neate C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gelber R; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA., Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Squifflet P; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Saad ED; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Heinzmann D; Product Development-Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Denkert C; Institut für Pathologie, Philipps-Universität Marburg und Universitätsklinikum Marburg, Marburg, Germany., Rastogi P; NSABP Foundation and University of Pittsburgh/Hillman Cancer Center, Pittsburgh, PA., Cortes J; IOB Institute of Oncology, Quiron Group, Madrid & Barcelona and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., de Azambuja E; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Cameron D; Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, Edinburgh, United Kingdom., Ismael G; Fundação Doutor Amaral Carvalho, Jaú, Brazil., Wolmark N; NSABP Foundation and University of Pittsburgh/Hillman Cancer Center, Pittsburgh, PA., Cortazar P; Genentech, Inc, South San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jun 01; Vol. 41 (16), pp. 2998-3008. Date of Electronic Publication: 2023 Apr 19.
Autor:
van Mackelenbergh MT; German Breast Group, Neu-Isenburg, Germany; Department of Gynecology and Obstetrics, Universitätsklinikum Schleswig-Holstein, Kiel, Germany. Electronic address: marion.vanmackelenbergh@gbg.de., Seither F; German Breast Group, Neu-Isenburg, Germany., Möbus V; University Hospital Frankfurt, Frankfurt, Germany., O'Shaughnessy J; US Oncology Research, Inc., The Woodlands, TX, USA; Texas Oncology/Baylor University Medical Center, Dallas, TX, USA., Martin M; Instituto de Investigacion Sanitaria Gregorio Marañon, CIBERONC, Universidad Complutense, Madrid, Spain; Spanish Breast Cancer Group, GEICAM, Madrid, Spain., Joensuu H; Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Untch M; Helios Kliniken Berlin-Buch, Berlin, Germany., Nitz U; Breast Center Niederrhein, Evangelical Hospital Johanniter Bethesda, Mönchengladbach, Germany., Steger GG; Department of Internal Medicine I and Gaston H. Glock Research Centre, Medical University of Vienna, Vienna, Austria., Miralles JJ; Spanish Breast Cancer Group, GEICAM, Madrid, Spain., Barrios CH; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Grupo Oncoclinicas, Porto Alegre, Brazil., Toi M; Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Bear HD; NRG Oncology and Division of Surgical Oncology, Massey Cancer Center, Virginia Commonwealth University, VCU Health, Richmond, VA, USA., Muss H; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Reimer T; Breast Center, University of Rostock, Rostock, Germany., Nekljudova V; German Breast Group, Neu-Isenburg, Germany., Loibl S; German Breast Group, Neu-Isenburg, Germany.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 May; Vol. 166, pp. 185-201. Date of Electronic Publication: 2022 Mar 16.
Autor:
Flörkemeier I; Department of Gynaecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.; Pharmaceutical Institute, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrechts-University Kiel, 24118 Kiel, Germany., Steinhauer TN; Pharmaceutical Institute, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrechts-University Kiel, 24118 Kiel, Germany., Hedemann N; Department of Gynaecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany., Weimer JP; Department of Gynaecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany., Rogmans C; Department of Gynaecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany., van Mackelenbergh MT; Department of Gynaecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany., Maass N; Department of Gynaecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany., Clement B; Pharmaceutical Institute, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrechts-University Kiel, 24118 Kiel, Germany., Bauerschlag DO; Department of Gynaecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Dec 21; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 21.
Autor:
Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Tudini E; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Li H; Cancer Control and Population Science, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Wappenschmidt B; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Feliubadaló L; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Aalfs CM; Department of Clinical Genetics, Amsterdam UMC, Amsterdam, The Netherlands., Agata S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy., Aittomäki K; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Alducci E; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy., Alonso-Cerezo MC; Clinical Genetics, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria, Madrid, Spain., Arnold N; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.; Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Auber B; Institute of Human Genetics, Hannover Medical School, Hannover, Germany., Austin R; Genetic Health Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia., Azzollini J; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Balmaña J; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, University Hospital of Vall d'Hebron, Barcelona, Spain., Barbieri E; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy., Bartram CR; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany., Blanco A; Fundación Pública galega Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain., Blümcke B; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Bonache S; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Bortesi B; Division of Oncology, University Hospital of Parma, Parma, Italy., Brunet J; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Bruzzone C; Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Bucksch K; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Cagnoli G; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Caldés T; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain., Caliebe A; Institute of Human Genetics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Caligo MA; SOD Genetica Molecolare, University Hospital, Pisa, Italy., Calvello M; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Capone GL; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Florence, Italy., Caputo SM; Service de Génétique, Institut Curie, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Carnevali I; UO Anatomia Patologica, Ospedale di Circolo ASST Settelaghi, Varese, Italy., Carrasco E; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Caux-Moncoutier V; Service de Génétique, Institut Curie, Paris, France., Cavalli P; Servizio di Genetica, ASST di Cremona, Cremona, Italy., Cini G; Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Clarke EM; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Concolino P; Fondazione Policlinico Universitario A.Gemelli, IRCCS, Rome, Italy., Cops EJ; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Cortesi L; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Darder E; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., de la Hoya M; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain., Dean M; Laboratory of Translational Genomics, DCEG, National Cancer Institute, Gaithersburg, Maryland., Debatin I; Institute of Human Genetics, University Hospital Ulm, Ulm, Germany., Del Valle J; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Delnatte C; Laboratoire de Genetique Moleculaire, CHU Nantes, Nantes, France., Derive N; Service de Génétique, Institut Curie, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Diez O; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Clinical and Molecular Genetics Area, University Hospital Vall d'Hebron, Barcelona, Spain., Ditsch N; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany., Domchek SM; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Dutrannoy V; Institute of Medical and Human Genetics, Charité -Universitätsmedizin Berlin, Berlin, Germany., Eccles DM; Faculty of Medicine, University of Southampton, Southampton, UK., Ehrencrona H; Department of Clinical Genetics and Pathology, Laboratory Medicine, Office for Medical Services - Region Skåne, Lund, Sweden.; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Enders U; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Evans DG; Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Manchester, UK.; Genomic Medicine, North West Genomics hub, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Manchester, UK., Farra C; Medical Genetics, American University of Beirut Medical Center, Beirut, Lebanon., Faust U; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany., Felbor U; Institute of Human Genetics, University Medicine Greifswald, Greifswald, Germany., Feroce I; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Fine M; Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, Australia., Foulkes WD; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada., Galvao HCR; Oncogenetics Department, Barretos Cancer Hospital, São Paulo, Brazil., Gambino G; SOD Genetica Molecolare, University Hospital, Pisa, Italy., Gehrig A; Department of Human Genetics, University of Würzburg, Würzburg, Germany., Gensini F; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Florence, Italy., Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Germani A; Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University, Rome, Italy., Giesecke J; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Gismondi V; Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Gómez C; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Gómez Garcia EB; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands., González S; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Grau E; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Grill S; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany., Gross E; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany., Guerrieri-Gonzaga A; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Guillaud-Bataille M; Departement de Biopathologie, Gustave Roussy, Universite Paris-Saclay, Villejuif, France., Gutiérrez-Enríquez S; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Haaf T; Department of Human Genetics, University of Würzburg, Würzburg, Germany., Hackmann K; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany., Hansen TVO; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Harris M; Familial Cancer Centre, Monash Health, Clayton, Australia., Hauke J; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Heinrich T; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany., Hellebrand H; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany., Herold KN; The City of Hope, Duarte, California., Honisch E; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Horvath J; Institute of Human Genetics, University of Münster, Münster, Germany., Houdayer C; Department of Genetics, F76000 and Normandy University, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, Rouen, France., Hübbel V; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Iglesias S; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Izquierdo A; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., James PA; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Janssen LAM; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., Jeschke U; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany., Kaulfuß S; Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany., Keupp K; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Kiechle M; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany., Kölbl A; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany., Krieger S; Laboratoire de Biologie Clinique et Oncologique, Centre Francois Baclesse, Caen, France.; Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.; Normandie Université, UNICAEN, Caen, France., Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark., Kvist A; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Lalloo F; Genomic Medicine, North West Genomics hub, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Manchester, UK., Larsen M; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Lattimore VL; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Lautrup C; Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Ledig S; Institute of Human Genetics, University of Münster, Münster, Germany., Leinert E; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Lewis AL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Lim J; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia., Loeffler M; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., López-Fernández A; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Lucci-Cordisco E; UOC Genetica Medica, Fondazione Policlinico Universitario A.Gemelli IRCCS and Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Rome, Italy., Maass N; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Marabelli M; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Matricardi L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy., Meindl A; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany., Michelli RD; Oncogenetics Department, Barretos Cancer Hospital, São Paulo, Brazil., Moghadasi S; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., Moles-Fernández A; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy., Montalban G; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Monteiro AN; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida., Montes E; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Mori L; Department of Clinical and Experimental Science, University of Brescia c/o 2nd Internal Medicine, Hospital of Brescia, Brescia, Italy., Moserle L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy., Müller CR; Department of Human Genetics, University of Würzburg, Würzburg, Germany., Mundhenke C; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Naldi N; Division of Oncology, University Hospital of Parma, Parma, Italy., Nathanson KL; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Navarro M; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Nichols CB; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia., Niederacher D; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Nielsen HR; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark., Ong KR; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, UK., Pachter N; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia.; Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia., Palmero EI; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.; Barretos School of Health Sciences, Dr. Paulo Prata - FACISB, São Paulo, Brazil., Papi L; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Florence, Italy., Pedersen IS; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Peissel B; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Perez-Segura P; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain., Pfeifer K; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany., Pineda M; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Pohl-Rescigno E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Poplawski NK; Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, Australia.; School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, Australia., Porfirio B; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, University of Florence, Florence, Italy., Quante AS; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany., Ramser J; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen, Universität München, Munich, Germany., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.; Health Sciences School, University of Minho, Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal., Revillion F; Laboratoire d'Oncogenetique Moleculaire Humaine, Centre Oscar Lambret, Lille, France., Rhiem K; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Riboli B; Servizio di Genetica, ASST di Cremona, Cremona, Italy., Ritter J; Institute of Medical and Human Genetics, Charité -Universitätsmedizin Berlin, Berlin, Germany., Rivera D; Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Rofes P; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Rump A; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany., Salinas M; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Sánchez de Abajo AM; Servicio de Análisis Clínicos y Bioquímica Clínica, Complejo Hospitalario, Universitario Insular Materno-Infantil de Gran Canaria, Las Palmas de Gran Canaría, Spain., Schmidt G; Institute of Human Genetics, Hannover Medical School, Hannover, Germany., Schoenwiese U; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Seggewiß J; Institute of Human Genetics, University of Münster, Münster, Germany., Solanes A; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Steinemann D; Institute of Human Genetics, Hannover Medical School, Hannover, Germany., Stiller M; Institute of Human Genetics, University Hospital Leipzig, Leipzig, Germany., Stoppa-Lyonnet D; Service de Génétique, Institut Curie, Paris, France.; Department of Tumour Biology, INSERM U830, Paris, France.; Université Paris Descartes, Paris, France., Sullivan KJ; Genetic Health Service NZ- Northern Hub, Auckland District Health Board, Auckland, New Zealand., Susman R; Genetic Health Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia., Sutter C; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany., Tavtigian SV; Department of Oncological Services, University of Utah School of Medicine, Salt Lake City, Utah.; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Teo SH; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Department of Surgery, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia., Teulé A; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark., Tibiletti MG; UO Anatomia Patologica, Ospedale di Circolo ASST Settelaghi, Varese, Italy., Tischkowitz M; Department of Medical Genetics, University of Cambridge, Cambridge, UK., Tognazzo S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV, IRCCS, Padua, Italy., Toland AE; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio., Tornero E; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Törngren T; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Torres-Esquius S; High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Toss A; Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy., Trainer AH; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Department of medicine, University of Melbourne, Melbourne, Victoria, Australia., Tucker KM; Prince of Wales Clinical School, University of NSW, Sydney, New South Wales, Australia.; Hereditary Cancer Clinic, Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., van Mackelenbergh MT; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Varesco L; Unit of Hereditary Cancer, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Vargas-Parra G; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Varon R; Institute of Medical and Human Genetics, Charité -Universitätsmedizin Berlin, Berlin, Germany., Vega A; Fundación Pública galega Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain., Velasco Á; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Vesper AS; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Viel A; Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands., Wagner SA; Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, Frankfurt, Germany., Waha A; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Walker LC; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Walters RJ; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Wang-Gohrke S; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Weber BHF; Institute of Human Genetics, University Regensburg, Regensberg, Germany., Weichert W; Institute of Pathology, Technische Universität München, Munich, Germany., Wieland K; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Wiesmüller L; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Witzel I; Department of Gynecology, University Medical Center Hamburg, Hamburg, Germany., Wöckel A; Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany., Woodward ER; Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Manchester, UK.; Genomic Medicine, North West Genomics hub, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Manchester, UK., Zachariae S; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Zampiga V; Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Zeder-Göß C; Department of Gynecology and Obstetrics, University of Munich, Munich, Germany., Lázaro C; Hereditary Cancer Program, ONCOBELL-IDIBELL-IDIBGI-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., De Nicolo A; Cancer Genomics Program, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah., Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Publikováno v:
Human mutation [Hum Mutat] 2019 Sep; Vol. 40 (9), pp. 1557-1578.
Autor:
Schmidt T; Cancer Center North, Schleswig-Holstein University Hospital, D-24105 Kiel, Germany., Rudolph I; Hematology and Oncology Department, Jena University Hospital, D-04774 Jena, Germany., Wozniak T; Hematology and Oncology Department, Jena University Hospital, D-04774 Jena, Germany., Ruetters D; Hematology and Oncology Department, Jena University Hospital, D-04774 Jena, Germany., Van Mackelenbergh MT; Clinic of Obstetrics and Gynaecology, Schleswig-Holstein University Hospital, D-24105 Kiel, Germany., Huebner J; Hematology and Oncology Department, Jena University Hospital, D-04774 Jena, Germany.
Publikováno v:
Molecular and clinical oncology [Mol Clin Oncol] 2018 Sep; Vol. 9 (3), pp. 342-346. Date of Electronic Publication: 2018 Jun 28.